Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:50:42 +0200Tue, 12 Mar 2024 13:22:00 +0100Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/daxasHuman medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/daxasTue, 12 Mar 2024 13:22:00 +0100Human medicineDaxas-H-C-1179-X-0035 : EPAR - Assessment Report - Extensionhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500247953_en.pdfDaxas-H-C-1179-X-0035 : EPAR - Assessment Report - Extensionhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500247953_en.pdfWed, 25 Apr 2018 02:00:00 +0200Human medicine